Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II docetaxel trial in elderly patients with non-small cell lung cancer
ISRCTN27242710Phase 2Terminated
- Sponsor
- Maidstone and Tunbridge Wells NHS Trust
- Start
- Jan 2008
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of docetaxel in non-small cell lung cancer (NSCLC), sponsored by Maidstone and Tunbridge Wells NHS Trust. Primary endpoint: Response rate. Started Jan 2008; status: terminated.
02
Drugs
docetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ISRCTN27242710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN27242710.